Makoto Ohori

Makoto Ohori is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents, his work focuses on addressing critical health issues through innovative solutions.

Latest Patents

Ohori's latest patents include the development of an anti-human IL-23 receptor antibody. This invention provides an anti-human IL-23R antibody that exhibits excellent activity and cross-reactivity compared to conventional IL-23R antibodies. It offers methods for treating or preventing various diseases where human IL-23R plays a role in the pathogenesis. Another notable patent is for an anti-human IL-23 receptor antibody and encoding polynucleotides. This invention aims to provide an anti-human IL-23R antibody with superior activity and cross-reactivity, along with means for its use in preventing or treating diseases such as ophthalmic disease, inflammatory bowel disease, and psoriasis.

Career Highlights

Makoto Ohori is currently employed at Astellas Pharma GmbH, where he continues to advance his research in antibody development. His work is pivotal in creating therapies that target specific diseases, enhancing treatment options for patients.

Collaborations

Ohori collaborates with esteemed colleagues, including Takanori Sasaki and Hiromu Sato. Their combined expertise contributes to the innovative research and development of new therapeutic antibodies.

Conclusion

Makoto Ohori's contributions to the field of biotechnology, particularly in the development of anti-human IL-23 receptor antibodies, highlight his role as a leading inventor. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in various diseases.

Profile summary based on public USPTO records.